Pharm
Colchicine
search
Colchicine
, Colcrys
Indications
Acute
Gouty Arthritis
(adjunct to
NSAID
s)
Gout
prophylaxis (started with
Allopurinol
to prevent triggering acute attack)
Acute Pericarditis
Disadvantages
Less viable option (too expensive) now that generic preparations were removed from the market
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm227796.htm
Use
NSAID
s instead
Contraindications
Severe renal or liver disease (see adverse effects below)
If used, limit to the 3 dose protocol below and do not repeat for 2 weeks
Do not use with
Cyclosporine
or
Cytochrome P450
3A4 Inhibitor if severe liver or renal disease (lethal interaction)
Dosing
Gout
in normal
Renal Function
See
Gout
for prophylaxis protocol when starting allopurinal
Tolerable Protocol (as adjunct to
NSAID
s)
Start within 24 hours of attack
Option 1: Colchicine 0.6 mg orally twice daily
Option 2: Colchicine 0.6 mg two taken immediately, then a third one hour later
New protocol (2010) - recommended dosing for Colcrys
Old Protocol (Not recommended - poorly tolerated due to
Diarrhea
, serious toxicity)
Start: 1.0 mg given within 24 hours of attack
Then: 0.5 mg each hour or 1.0 mg every 2 hours prn
Endpoints
Joint Pain
improves
Diarrhea
Maximum Dose: 6 mg in 24 hours
Dosing
Renal dose adjustment
GFR >50 ml/minute: 0.6 mg orally twice daily
GFR 35-50 ml/minute: 0.6 mg orally once daily
GFR 10-34 ml/minute: 0.6 mg orally every 2-3 days
GFR <10 ml/minute: Do NOT use
Adverse Effects
Gastrointestinal toxicity (limits dosing)
Nausea
or
Vomiting
Diarrhea
Bone Marrow
suppression (esp. if severe liver or renal disease)
Reversible
Axon
al Neuromyopathy (1% of cases)
Increased risk if severe liver or renal disease
Alopecia
Monitoring
Baseline and repeated at 1 month
Complete Blood Count
Liver
transaminases (AST, ALT)
Creatine Phosphokinase
(CPK)
Serum Creatinine
Drug Interactions
Cyclosporine
Cytochrome P450
3A4 inhibitors (e.g.
Clarithromycin
,
Verapamil
)
Do not use with with
Macrolide
s (e.g.
Clarithromycin
,
Azithromycin
,
Erythromycin
)
Drug Interaction
s also occur with
P-Glycoprotein Inhibitor
s
Avoid
Grapefruit
Rhabdomyolysis
risk
Increased risk when combined with
Statin
s or
Clarithromycin
Increased risk with older patients and those with
Chronic Kidney Disease
References
(2011) Presc Lett 18(12): 70
Borstad (2004) J Rheumatol 31:2429-32 [PubMed]
Type your search phrase here